5 Nov 2019
Home » Uncategorized » OB Pharmaceuticals CSO, Dr. Michael Poulter in the News

OB Pharmaceuticals CSO, Dr. Michael Poulter in the News

by | posted in: Michael Poulter, Uncategorized | 0

OB Pharmaceuticals CSO, Dr. Michael Poulter in the News

LONDON, ONTARIO May 16, 2019 -- OB Pharmaceuticals CSO, Dr. Michael Poulter in the News.

Dr. Michael Poulter, CSO was interviewed for CTV News discussing his latest research investigating the mechanisms of traumatic brain injury (TBI) induced seizures. For the full interview, watch: https://london.ctvnews.ca/new-hope-for-treating-epilepsy-developed-after-traumatic-brain-injury-1.4425431.